XBiotech Inc.
XBIT
$2.27
-$0.04-1.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.30M | 4.83M | 4.64M | 5.62M | 4.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 55.69M | 34.68M | 36.54M | 45.17M | 42.47M |
| Operating Income | -55.69M | -34.68M | -36.54M | -45.17M | -42.47M |
| Income Before Tax | -45.31M | -29.04M | -28.14M | -39.44M | -38.56M |
| Income Tax Expenses | 235.00K | 118.00K | 25.00K | -28.00K | -32.00K |
| Earnings from Continuing Operations | -45.54 | -29.16 | -28.16 | -39.41 | -38.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.54M | -29.16M | -28.16M | -39.41M | -38.53M |
| EBIT | -55.69M | -34.68M | -36.54M | -45.17M | -42.47M |
| EBITDA | -54.00M | -32.93M | -34.78M | -43.41M | -40.73M |
| EPS Basic | -1.49 | -0.96 | -0.92 | -1.29 | -1.27 |
| Normalized Basic EPS | -0.94 | -0.60 | -0.58 | -0.81 | -0.79 |
| EPS Diluted | -1.49 | -0.96 | -0.92 | -1.29 | -1.27 |
| Normalized Diluted EPS | -0.94 | -0.60 | -0.58 | -0.81 | -0.79 |
| Average Basic Shares Outstanding | 121.95M | 121.93M | 121.91M | 121.88M | 121.84M |
| Average Diluted Shares Outstanding | 121.95M | 121.93M | 121.91M | 121.88M | 121.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |